A detailed history of Cinctive Capital Management LP transactions in Veracyte, Inc. stock. As of the latest transaction made, Cinctive Capital Management LP holds 109,015 shares of VCYT stock, worth $4.27 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
109,015
Previous 104,673 4.15%
Holding current value
$4.27 Million
Previous $2.27 Million 63.54%
% of portfolio
0.22%
Previous 0.11%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$21.0 - $35.25 $91,182 - $153,055
4,342 Added 4.15%
109,015 $3.71 Million
Q2 2024

Aug 14, 2024

BUY
$18.86 - $23.55 $1.97 Million - $2.47 Million
104,673 New
104,673 $2.27 Million
Q1 2022

May 16, 2022

SELL
$21.94 - $42.51 $512,628 - $993,246
-23,365 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$36.09 - $53.79 $843,242 - $1.26 Million
23,365 New
23,365 $963,000

Others Institutions Holding VCYT

About VERACYTE, INC.


  • Ticker VCYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,575,904
  • Market Cap $2.81B
  • Description
  • Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...
More about VCYT
Track This Portfolio

Track Cinctive Capital Management LP Portfolio

Follow Cinctive Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cinctive Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Cinctive Capital Management LP with notifications on news.